Giuseppe Barone Advances in Neuroblastoma Research Congress 2016

Abstracts this author is presenting:

• The CHK1 inhibitor CCT244747, alone and in combination with gemcitabine, is active against p53 deficient models of neuroblastoma resistant to chemotherapy. — Poster Session 2 with wine & cheese
• A comprehensive preclinical study of ALK inhibitors for the efficacious treatment of ALK^F1174L/MYCN-driven neuroblastoma — Poster Session 2 with wine & cheese
• A native and immunocompetent in vivo model of chemorefractory, bone-marrow metastatic, “ultra-high risk” neuroblastoma. — Parallel 2 Liquid Biopsies, Circulating Tumour Cells and Metastasis